SciPost Submission Page
Recent results from LHCb for astroparticle physics
by Hans Dembinski on behalf of the LHCb collaboration
This is not the latest submitted version.
This Submission thread is now published as
Submission summary
| Authors (as registered SciPost users): | Hans Dembinski |
| Submission information | |
|---|---|
| Preprint Link: | scipost_202208_00024v1 (pdf) |
| Date submitted: | 2022-08-13 22:27 |
| Submitted by: | Dembinski, Hans |
| Submitted to: | SciPost Physics Proceedings |
| Proceedings issue: | 21st International Symposium on Very High Energy Cosmic Ray Interactions (ISVHECRI2022) |
| Ontological classification | |
|---|---|
| Academic field: | Physics |
| Specialties: |
|
| Approaches: | Experimental, Phenomenological, Observational |
Abstract
The LHCb experiment is a general-purpose forward spectrometer designed for the study of heavy flavour physics at the LHC. The acceptance in the pseudorapidity range 2 < eta < 5 with full tracking and particle identification capabilities down to very small transverse momentum make LHCb also ideal to study hadron production in the forward region. Measuring and modelling these processes is essential for the simulation of interactions of high-energy cosmic rays with matter, like Earth's atmosphere or the interstellar medium. We present recently published analyses from the LHCb collaboration relevant for this application.
Current status:
Reports on this Submission
Anonymous Report 1 on 2022-9-24 (Invited Report)
- Cite as: Anonymous, Report on arXiv:scipost_202208_00024v1, delivered 2022-09-24, doi: 10.21468/SciPost.Report.5756
Report
The manuscript is already well-written and clear. There needs no major comment.
I would ask to correct typos and suggest a few minor comments for further improvement.
1) In Section 1, "the cora-corona model" should be "the core-corona model".
2) In Section 2, it would be good to give a description or definition of the nuclear medication factor, R_pPb.
3) In Section 3, root(s_NN) would be first introduced here for the proton-lead collisions at 8.16 TeV, since you use it later in Section 6.
4) In Section 5, it may be good to indicate the rapidity coverage of VELO if it is available. Also is it possible to clarify the tracks at VELO mainly come from non-diffractive collisions or diffractive collisions ?
Author: Hans Dembinski on 2022-10-04 [id 2871]
(in reply to Report 1 on 2022-09-24)Thank you for the review. I made edits to clarify points 1 to 4. Regarding the question whether VELO tracks mainly come from non-diffractive or diffractive collisions, I don't know for sure and I don't know where to look it up. At mid-rapidity, diffractive effects contribute about 25 % of the total cross-section, but I don't know how many particles, and I don't know how that changes when you further forward. The fraction of particles produced by diffractive events should increase with |Ī·|.
Anonymous on 2022-09-24 [id 2848]
The manuscript is already well-written and clear. There needs no major comment. I would ask to correct typos and suggest a few minor comments for further improvement.
1) In Section 1, "the cora-corona model" should be "the core-corona model".
2) In Section 2, it would be good to give a description or definition of the nuclear medication factor, R_pPb.
3) In Section 3, root(s_NN) would be first introduced here for the proton-lead collisions at 8.16 TeV, since you use it later in Section 6.
4) In Section 5, it may be good to indicate the rapidity coverage of VELO if it is available. Also is it possible to clarify the tracks at VELO mainly come from non-diffractive collisions or diffractive collisions ?